earnings
VR
NASDAQ · VRCA
Verrica Pharmaceuticals Inc.
Healthcare · Biotechnology
$3.35
Down-$0.07 (-2.05%)
Updated Nov 1, 2026, 3:20 AM
SID Score
3.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 79.81M
- P/E ratio
- -3.07
- Dividend yield
- 0.00%
- 52-week range
- $3.25 – $8.50
- Volume
- 33.79K
- Avg. volume
- 399.36K
Price performance · VRCA
VRCA price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
VRCA closed at $3.35 after 20 trading sessions, down 22.27% for the selected period.
- Last close
- $3.35
- Period change
- -22.27%
- Period low
- $3.35
- Period high
- $4.31
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $3.42 | $3.49 | $3.25 | $3.35 | 33.79K |
| Oct 29, 2026 | $3.48 | $3.62 | $3.39 | $3.42 | 29.72K |
| Oct 28, 2026 | $3.45 | $3.565 | $3.39 | $3.48 | 22.37K |
| Oct 27, 2026 | $3.36 | $3.52 | $3.335 | $3.47 | 27.99K |
| Oct 26, 2026 | $3.55 | $3.68 | $3.39 | $3.42 | 21.94K |
| Oct 23, 2026 | $3.76 | $3.76 | $3.40 | $3.53 | 21.01K |
| Oct 22, 2026 | $3.50 | $4.17 | $3.50 | $3.83 | 109.91K |
| Oct 21, 2026 | $3.46 | $3.64 | $3.4414 | $3.63 | 60.44K |
| Oct 20, 2026 | $3.44 | $3.56 | $3.30 | $3.47 | 77.18K |
| Oct 19, 2026 | $3.61 | $3.645 | $3.42 | $3.44 | 79.83K |
| Oct 16, 2026 | $3.85 | $3.95 | $3.48 | $3.595 | 116.47K |
| Oct 15, 2026 | $3.92 | $3.95 | $3.746 | $3.78 | 64.3K |
| Oct 14, 2026 | $3.54 | $3.92 | $3.50 | $3.83 | 54.86K |
| Oct 13, 2026 | $3.99 | $4.38 | $3.51 | $3.58 | 85.86K |
| Oct 12, 2026 | $4.20 | $4.20 | $4.00 | $4.01 | 48.71K |
| Oct 9, 2026 | $4.37 | $4.37 | $4.06 | $4.11 | 46.55K |
| Oct 8, 2026 | $4.14 | $4.29 | $4.05 | $4.18 | 37.19K |
| Oct 7, 2026 | $4.15 | $4.3299 | $4.06 | $4.14 | 47.65K |
| Oct 6, 2026 | $4.36 | $4.41 | $4.17 | $4.21 | 41.31K |
| Oct 5, 2026 | $4.34 | $4.5387 | $4.25 | $4.31 | 35.04K |
Latest VRCA news
The latest Smart Investors Daily articles mentioning VRCA.
Stock researchResearch & News · News
Company
Market Activity
Research & News
Loading stock research…

